PRESS DIGEST- Financial Times - June 2

June 1 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

-Bidders for BP's Castrol weigh offers below expected $8bln valuation

-AstraZeneca unveils drug to treat mutating breast cancer before it starts to grow

-UK to urge Trump administration to implement zero-tariff steel accord

-UK industrial strategy must deal with high energy costs, business warns

- Britain to build up to 12 attack submarines as it moves to war-ready footing

Overview

- BP's BP.L sale of its lubricants arm Castrol has drawn early interest from private equity and industry bidders, including China's state-owned investment company Citic, although some are considering offers below the expected $8billion-plus range.

- AstraZeneca AZN.L has unveiled positive trial results for a breast cancer drug that can stop mutating tumours before they start to grow, hoping it will be one of a portfolio of medicines that will propel it to become the world leader in oncology.

- UK business and trade secretary, Jonathan Reynolds will next week urge Donald Trump's administration to quickly put in place a deal to cut taxes on UK steel exports to zero, even after the US president vowed to double his global steel tariff to 50 per cent.

- Prime Minister Keir Starmer has been warned by British business that his vaunted industrial strategy, to be published this month, will be “fatally flawed” unless it deals comprehensively with the country’s very high energy costs.

- Britain will build roughly a dozen new attack submarines as it moves to a state of "warfighting readiness", Keir Starmer will say on Monday, as he begins what he claims will be a major rearmament programme.